$146.36
2.09%
NYSE, Oct 31, 09:00 pm CET

Agilent Technologies Stock price

$146.36
+18.01 14.03% 1M
+38.76 36.02% 6M
+12.02 8.95% YTD
+16.05 12.32% 1Y
+8.01 5.79% 3Y
+41.12 39.07% 5Y
+107.77 279.27% 10Y
+123.47 539.41% 20Y
NYSE, Closing price Fri, Oct 31 2025
+3.00 2.09%

Key metrics

Basic
Market capitalization
$41.5b
Enterprise Value
$43.4b
Net debt
$1.9b
Cash
$1.5b
Shares outstanding
283.6m
Valuation (TTM | estimate)
P/E
34.3 | 25.7
P/S
6.1 | 5.9
EV/Sales
6.4 | 6.1
EV/FCF
39.9
P/B
6.5
Dividends
DPS
$0.99
Yield 1Y | 5Y
0.7% | 0.7%
Growth 1Y | 5Y
5.1% | 6.6%
Payout 1Y | 3Y
21.3% | 21.0%
Increased
14 Years
Financials (TTM | estimate)
Revenue
$6.8b | $7.1b
EBITDA
$1.8b | $2.0b
EBIT
$1.5b | $1.8b
Net Income
$1.2b | $1.6b
Free Cash Flow
$1.1b
Growth (TTM | estimate)
Revenue
4.5% | 8.4%
EBITDA
-2.5% | 12.3%
EBIT
-5.1% | 12.5%
Net Income
-13.7% | 25.1%
Free Cash Flow
-23.2%
Margin (TTM | estimate)
Gross
52.9%
EBITDA
26.7% | 29.0%
EBIT
22.4%
Net
18.0% | 22.9%
Free Cash Flow
16.0%
Financial Health
Equity Ratio
49.8%
Return on Equity
21.9%
ROCE
14.7%
ROIC
14.0%
Debt/Equity
0.5
More
EPS
$4.3
FCF per Share
$3.8
Short interest
1.4%
Employees
18k
Rev per Employee
$360.0k
Show more

Is Agilent Technologies a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Agilent Technologies Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Agilent Technologies forecast:

14x Buy
54%
12x Hold
46%

Analyst Opinions

26 Analysts have issued a Agilent Technologies forecast:

Buy
54%
Hold
46%

Financial data from Agilent Technologies

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jul '25
+/-
%
6,788 6,788
4% 4%
100%
- Direct Costs 3,196 3,196
9% 9%
47%
3,592 3,592
1% 1%
53%
- Selling and Administrative Expenses 1,626 1,626
9% 9%
24%
- Research and Development Expense 443 443
3% 3%
7%
1,809 1,809
2% 2%
27%
- Depreciation and Amortization 286 286
14% 14%
4%
EBIT (Operating Income) EBIT 1,523 1,523
5% 5%
22%
Net Profit 1,220 1,220
14% 14%
18%

In millions USD.

Don't miss a Thing! We will send you all news about Agilent Technologies directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Agilent Technologies Stock News

Neutral
Business Wire
4 days ago
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2025 after the stock market closes on Monday, Nov. 24. The company will host a conference call to discuss the results at 1:30 p.m. PST the same day. To join the listen-only conference call webcast, click the link on the Events section of Agilent's Invest...
Neutral
Business Wire
7 days ago
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the appointment of Adam S. Elinoff as chief financial officer, effective Nov. 17. Elinoff brings two decades of financial experience spanning corporate finance, investor relations, strategy and business transformation, and has a proven record of driving enterprise-wide transformations, optimizing financial...
Positive
Proactive Investors
about one month ago
Citi analysts had a “constructive” meeting with Agilent Technologies Inc (NYSE:A) management this week, given the various growth drivers for the company into next year.  This “should translate into earnings leverage," the analysts wrote in a note to clients on Thursday.
More Agilent Technologies News

Company Profile

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Head office United States
CEO Padraig Mcdonnell
Employees 17,900
Founded 1999
Website www.agilent.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today